KRISHNA INST OF MED SCI L
Latest filings
Next results: Wed, 4 Nov · Financial Results- Board to approve Q2 and half-year results on November 4, 2026 · Results
- Analyst and institutional investor meeting scheduled for November 16, 2026 · Board & Shareholder Meetings
- Quarterly Reg 74(5) DP compliance certificate filed · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates a multi-specialty hospital chain across several Indian states including Telangana, Andhra Pradesh, Karnataka, Maharashtra, and Kerala. Revenue is generated from inpatient and outpatient hospital services, with Q4 FY26 inpatient volumes up 17.9% YoY and outpatient volumes up 30.1% YoY. The company expanded into 8 new locations in FY26 — Kompally, Guntur (two facilities), Thane, Sangli, Bangalore Mahadevapura and Electronic City, Kerala Kollam, plus a mother-and-child unit at Nellore — and is consolidating the 300-bed Palakkad acquisition. Mature hospitals run at ~29.5% EBITDA margin, while overall FY26 EBITDA margin was 20.9% as newly commissioned units dragged INR 128 crore on EBITDA. Employee costs of 17.5% of revenue are the largest disclosed cost line, with capex at 36.6% of revenue reflecting the build-out. A INR 1,500 crore QIP closed in June 2026 is being used to retire ~INR 1,000 crore of debt and target net debt/EBITDA of ~2x against ~3.5x currently.
Scorecard
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from KRISHNA INST OF MED SCI L's filed financials and exchange disclosures
What does KRISHNA INST OF MED SCI L do?
KRISHNA INST OF MED SCI L is a Healthcare Services company listed on NSE and BSE, trading under the symbol KIMS.
Is KRISHNA INST OF MED SCI L profitable?
Yes. Over the trailing twelve months KRISHNA INST OF MED SCI L reported a net profit of ₹194 Cr on revenue of ₹4,213 Cr.
Does KRISHNA INST OF MED SCI L pay a dividend?
Yes. The dividend yield is 0.71% at the current price. It paid out 86% of its profit as dividend in FY26.
Is KRISHNA INST OF MED SCI L debt-free?
No. It reported borrowings of ₹3,244 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹3,189 Cr after cash. Debt stands at 1.27× equity. That is higher than 100% of its 24 Hospital peers.
Is KRISHNA INST OF MED SCI L expensive compared with its peers?
On trailing P/E, KRISHNA INST OF MED SCI L ranks 28 of 30 in Hospital — cheaper than 7% of them, against an industry median of 42.1×. This is a position, not a valuation judgement.
How much does the KRISHNA INST OF MED SCI L share price move in a day?
On a typical session KRISHNA INST OF MED SCI L moves 1.15% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are KRISHNA INST OF MED SCI L's next results?
Financial Results on Wed, 4 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track KRISHNA INST OF MED SCI L's announcements?
Every NSE and BSE filing by KRISHNA INST OF MED SCI L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.